[Product Name] Enzalutamide Capsules

[English Name] Enzalutamide Capsules

[Specification] 40mg × 112 capsules/box

[Manufacturer] APRAZER HEALTHCARE PVT LTD

Enzalutamide is a medication used to treat prostate cancer, specifically metastatic prostate cancer. It is a form of anti-androgen therapy that works by inhibiting the effects of androgens on prostate cancer cells. The drug has demonstrated excellent performance in clinical trials, showing significant efficacy and a favorable safety profile. The recommended dosage of Enzalutamide is 160 mg, administered orally once daily.

Enzalutamide is a medication used to treat prostate cancer. It belongs to the class of anti-androgen drugs and is widely used for treating advanced or metastatic prostate cancer. By inhibiting androgen receptor (AR) activity in the body, Enzalutamide effectively controls the growth and spread of prostate cancer. The following details the drug's prescribing information and usage instructions.

1. Indications

Enzalutamide is indicated for the treatment of metastatic hormone-sensitive prostate cancer—that is, prostate cancer that has spread to other parts of the body but remains responsive to androgen-deprivation therapy. It is also indicated for patients with non-metastatic hormone-sensitive prostate cancer who have rising prostate-specific antigen (PSA) levels.

2. Administration

Enzalutamide is supplied as oral capsules. The recommended adult dosage is 160 mg (four capsules) daily, taken in two divided doses of 80 mg (two capsules) each. Capsules should be swallowed whole, ideally at the same time each day. During treatment, patients should avoid sharing utensils, tableware, or personal hygiene items with others.

3. Precautions

Before using Enzalutamide, please inform your doctor about your allergy history, existing medical conditions, and any other medications you are currently taking. Certain drugs may interact with Enzalutamide, potentially affecting its efficacy or increasing the risk of side effects. Your doctor will carefully evaluate your condition and adjust your medication regimen as necessary.

While taking enzalutamide, your doctor may periodically monitor your blood parameters and physical condition. Please undergo the recommended tests and follow-up visits, and adhere to the prescribed medication plan.

4. Adverse Reactions

Enzalutamide may cause adverse reactions, including fatigue, weakness, headache, gastrointestinal discomfort, a burning sensation, hypertension, and abnormal liver function. Seek immediate medical attention if you experience severe adverse reactions, such as difficulty breathing, rapid heartbeat, or severe chest pain.

Specifications

Product Name: Enzalutamide Capsules 40mg x 112 capsules/box (Indenza Enzalutamide Capsules 40mg)

Common Name: Enzalutamide Capsules

Active Ingredient: Enzalutamide

Dosage Form: Capsule

Specification: 40mg x 112 capsules/box

Manufacturer: APRAZER HEALTHCARE PVT LTD

Indications: Enzalutamide is indicated for the treatment of metastatic hormone-sensitive prostate cancer—prostate cancer that has spread to other parts of the body and remains sensitive to androgen therapy. It is also used to treat patients with non-metastatic hormone-sensitive prostate cancer presenting with rising prostate-specific antigen (PSA) levels.

Dosage and Administration: Enzalutamide is supplied as oral capsules. The recommended daily dose for adult patients is 160 mg (4 capsules), taken orally in two divided doses of 80 mg (2 capsules) each. The capsules should be swallowed whole, ideally at the same time each day. During treatment, patients should avoid sharing cutlery, tableware, or personal hygiene items with others.